S&P 500   4,962.34 (-0.97%)
DOW   37,949.95 (+0.46%)
QQQ   414.84 (-2.02%)
AAPL   165.11 (-1.16%)
MSFT   399.28 (-1.23%)
META   479.55 (-4.43%)
GOOGL   153.82 (-1.40%)
AMZN   174.34 (-2.72%)
TSLA   147.17 (-1.84%)
NVDA   769.00 (-9.18%)
AMD   146.41 (-5.59%)
NIO   3.81 (-4.75%)
BABA   69.03 (+0.22%)
T   16.42 (+0.55%)
F   12.11 (+0.41%)
MU   106.73 (-4.65%)
GE   148.53 (-2.88%)
CGC   7.99 (+2.04%)
DIS   112.27 (-0.14%)
AMC   3.18 (+8.90%)
PFE   25.97 (+2.28%)
PYPL   61.99 (-0.18%)
XOM   119.84 (+1.11%)
S&P 500   4,962.34 (-0.97%)
DOW   37,949.95 (+0.46%)
QQQ   414.84 (-2.02%)
AAPL   165.11 (-1.16%)
MSFT   399.28 (-1.23%)
META   479.55 (-4.43%)
GOOGL   153.82 (-1.40%)
AMZN   174.34 (-2.72%)
TSLA   147.17 (-1.84%)
NVDA   769.00 (-9.18%)
AMD   146.41 (-5.59%)
NIO   3.81 (-4.75%)
BABA   69.03 (+0.22%)
T   16.42 (+0.55%)
F   12.11 (+0.41%)
MU   106.73 (-4.65%)
GE   148.53 (-2.88%)
CGC   7.99 (+2.04%)
DIS   112.27 (-0.14%)
AMC   3.18 (+8.90%)
PFE   25.97 (+2.28%)
PYPL   61.99 (-0.18%)
XOM   119.84 (+1.11%)
S&P 500   4,962.34 (-0.97%)
DOW   37,949.95 (+0.46%)
QQQ   414.84 (-2.02%)
AAPL   165.11 (-1.16%)
MSFT   399.28 (-1.23%)
META   479.55 (-4.43%)
GOOGL   153.82 (-1.40%)
AMZN   174.34 (-2.72%)
TSLA   147.17 (-1.84%)
NVDA   769.00 (-9.18%)
AMD   146.41 (-5.59%)
NIO   3.81 (-4.75%)
BABA   69.03 (+0.22%)
T   16.42 (+0.55%)
F   12.11 (+0.41%)
MU   106.73 (-4.65%)
GE   148.53 (-2.88%)
CGC   7.99 (+2.04%)
DIS   112.27 (-0.14%)
AMC   3.18 (+8.90%)
PFE   25.97 (+2.28%)
PYPL   61.99 (-0.18%)
XOM   119.84 (+1.11%)
S&P 500   4,962.34 (-0.97%)
DOW   37,949.95 (+0.46%)
QQQ   414.84 (-2.02%)
AAPL   165.11 (-1.16%)
MSFT   399.28 (-1.23%)
META   479.55 (-4.43%)
GOOGL   153.82 (-1.40%)
AMZN   174.34 (-2.72%)
TSLA   147.17 (-1.84%)
NVDA   769.00 (-9.18%)
AMD   146.41 (-5.59%)
NIO   3.81 (-4.75%)
BABA   69.03 (+0.22%)
T   16.42 (+0.55%)
F   12.11 (+0.41%)
MU   106.73 (-4.65%)
GE   148.53 (-2.88%)
CGC   7.99 (+2.04%)
DIS   112.27 (-0.14%)
AMC   3.18 (+8.90%)
PFE   25.97 (+2.28%)
PYPL   61.99 (-0.18%)
XOM   119.84 (+1.11%)
OTCMKTS:SEOVF

Sernova (SEOVF) Stock Price, News & Analysis

$0.33
0.00 (0.00%)
(As of 04/18/2024 ET)
Today's Range
$0.33
$0.34
50-Day Range
$0.29
$0.51
52-Week Range
$0.29
$0.83
Volume
29,167 shs
Average Volume
19,754 shs
Market Capitalization
$99.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.50
SEOVF stock logo

About Sernova Stock (OTCMKTS:SEOVF)

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.

SEOVF Stock Price History

SEOVF Stock News Headlines

Sernova Names Nicholas Rossettos Interim CFO
Strange new buyer driving up gold
One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."
Closing Bell: Sernova Corp flat on Tuesday (SVA)
Strange new buyer driving up gold
One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."
Sernova Appoints Cynthia Pussinen as Chief Executive
Sernova appoints CEO
Sernova (SVA) Receives a Buy from H.C. Wainwright
Echelon Wealth Partners Remains a Buy on Sernova (SVA)
Closing Bell: Sernova Corp flat on Monday (SVA)
Closing Bell: Sernova Corp flat on Thursday (SVA)
See More Headlines
Receive SEOVF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sernova and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/18/2024
Today
4/19/2024
Next Earnings (Estimated)
6/12/2024
Fiscal Year End
10/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:SEOVF
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.50
High Stock Price Target
$1.50
Low Stock Price Target
$1.50
Potential Upside/Downside
+355.2%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$-28,910,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.03 per share

Miscellaneous

Free Float
N/A
Market Cap
$99.97 million
Optionable
Not Optionable
Beta
1.16
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Ms. Cynthia Pussinen
    CEO & Director
  • Dr. Philip M. Toleikis B.A.
    M.Sc., Ph.D., President, CTO, Director of Technology & Director
  • Dr. Modestus Obochi M.B.A.
    Ph.D., Chief Business Officer
  • Dr. Frank Shannon M.D.
    Vice President of Clinical Development & Regulatory Affairs
  • Mr. Nicholas J. Rossettos CPA (Age 58)
    M.B.A., Interim Chief Financial Officer
  • Mr. Douglas Maret
    Chief Science Officer
  • Mr. Christopher Barnes
    Vice President of Investor Relations

SEOVF Stock Analysis - Frequently Asked Questions

Should I buy or sell Sernova stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sernova in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" SEOVF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SEOVF, but not buy additional shares or sell existing shares.
View SEOVF analyst ratings
or view top-rated stocks.

What is Sernova's stock price target for 2024?

1 brokers have issued 1-year price objectives for Sernova's stock. Their SEOVF share price targets range from $1.50 to $1.50. On average, they predict the company's stock price to reach $1.50 in the next twelve months. This suggests a possible upside of 355.2% from the stock's current price.
View analysts price targets for SEOVF
or view top-rated stocks among Wall Street analysts.

How have SEOVF shares performed in 2024?

Sernova's stock was trading at $0.5328 at the beginning of the year. Since then, SEOVF shares have decreased by 38.2% and is now trading at $0.3295.
View the best growth stocks for 2024 here
.

Are investors shorting Sernova?

Sernova saw a drop in short interest in March. As of March 15th, there was short interest totaling 110,400 shares, a drop of 19.9% from the February 29th total of 137,900 shares. Based on an average daily volume of 47,100 shares, the days-to-cover ratio is currently 2.3 days.
View Sernova's Short Interest
.

When is Sernova's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, June 12th 2024.
View our SEOVF earnings forecast
.

How were Sernova's earnings last quarter?

Sernova Corp. (OTCMKTS:SEOVF) released its earnings results on Monday, March, 18th. The company reported ($0.02) earnings per share for the quarter.

How do I buy shares of Sernova?

Shares of SEOVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:SEOVF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners